Greater anhedonia scores in healthy individuals are associated with less decline in 24-hour energy expenditure with fasting: Evidence for a link between behavioral traits and spendthrift phenotype.


Journal

Physiology & behavior
ISSN: 1873-507X
Titre abrégé: Physiol Behav
Pays: United States
ID NLM: 0151504

Informations de publication

Date de publication:
01 10 2023
Historique:
received: 03 04 2023
revised: 02 06 2023
accepted: 22 06 2023
pmc-release: 01 10 2024
medline: 24 7 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

Obesity rates are increasing and affecting mental health. It is important to understand how behavioral traits such as anhedonia are associated with physiologic traits that may predict weight-change in clinical and non-clinical populations. We studied whether 24-hour energy expenditure (24hEE) changes with fasting and overfeeding are associated with anhedonia in a healthy cohort. We performed behavioral assessments (physical anhedonia scale (PAS) and inventory for depressive symptoms (IDS)) followed by measures of 24hEE and urinary catecholamines in a whole-room indirect calorimeter (respiratory chamber) during energy balance, and then randomly during fasting and 2 different overfeeding diets. Participants (n=98) were medically healthy, between 18 and 55 years of age, with normal glucose regulation and weight-stable 6 months before admission. Women were premenopausal and not pregnant. Higher PAS was significantly associated with lesser decrease in 24hEE with fasting and higher urinary catecholamine excretion rates - consistent with spendthrift metabolism. As IDS increased, the association between anhedonia and the change in 24hEE from energy balance to fasting decreased (B-values were lower for change in EE). Here, higher PAS scores may reflect the ability to respond with appropriate homeostatic reactions which balance energy needs. IDS scores blunting this response may explain how anhedonia and depression can lead to weight gain.

Identifiants

pubmed: 37356515
pii: S0031-9384(23)00206-8
doi: 10.1016/j.physbeh.2023.114281
pmc: PMC10528212
mid: NIHMS1914239
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT00523627']

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

114281

Subventions

Organisme : Intramural NIH HHS
ID : Z99 DK999999
Pays : United States

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest none

Références

Biomedicines. 2021 Mar 13;9(3):
pubmed: 33805626
Int J Eat Disord. 2021 Mar;54(3):287-292
pubmed: 33295671
Am J Clin Nutr. 1991 Jun;53(6):1368-71
pubmed: 2035463
Biol Psychiatry. 2022 May 15;91(10):879-887
pubmed: 34344535
Early Interv Psychiatry. 2022 Feb;16(2):113-125
pubmed: 33735937
J Affect Disord. 2017 Jul;216:3-16
pubmed: 28237133
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 32118268
Diabetes. 2015 Nov;64(11):3680-9
pubmed: 26185280
Am J Physiol. 1984 Jul;247(1 Pt 1):E35-40
pubmed: 6742188
J Neuroendocrinol. 2008 Aug;20(8):978-87
pubmed: 18777604
J Psychosom Res. 1985;29(1):71-83
pubmed: 3981480
J Clin Endocrinol Metab. 2017 Jan 1;102(1):279-289
pubmed: 27820654
Curr Obes Rep. 2015 Sep;4(3):303-10
pubmed: 26627487
Psychiatry Res. 1986 May;18(1):65-87
pubmed: 3737788
Psychiatry Investig. 2020 Aug;17(8):715-724
pubmed: 32777922
Am J Clin Nutr. 2019 Sep 1;110(3):593-604
pubmed: 31172178
Endocrinology. 2010 Dec;151(12):5570-81
pubmed: 21047943
Diabetes Care. 2007 Jan;30 Suppl 1:S42-7
pubmed: 17192378
J Abnorm Psychol. 1976 Aug;85(4):374-82
pubmed: 956504
J Clin Invest. 1986 Dec;78(6):1568-78
pubmed: 3782471
Depress Anxiety. 2016 Oct;33(10):927-938
pubmed: 27699943
Psychoneuroendocrinology. 2005 Jun;30(5):453-60
pubmed: 15721057
CNS Neurosci Ther. 2018 Jul;24(7):615-623
pubmed: 29687627
Arch Gen Psychiatry. 1992 Jul;49(7):568-72
pubmed: 1627048
Diabetes. 2020 Feb;69(2):181-192
pubmed: 31712321
Acta Psychiatr Scand. 2015 Aug;132(2):97-108
pubmed: 26016380
Obesity (Silver Spring). 2017 Feb;25(2):332-337
pubmed: 28000375
J Affect Disord. 2014 Oct;168:306-13
pubmed: 25086289
Appetite. 2010 Dec;55(3):726-9
pubmed: 20801180
Nat Rev Neurosci. 2013 Sep;14(9):609-25
pubmed: 23942470
Psychiatr Clin North Am. 2017 Jun;40(2):255-266
pubmed: 28477651
Trends Neurosci. 2012 Jan;35(1):68-77
pubmed: 22177980
Am J Physiol. 1990 Sep;259(3 Pt 2):R470-7
pubmed: 2396705
J Psychiatr Res. 2010 Aug;44(11):707-16
pubmed: 20116072
Physiol Behav. 2022 Aug 1;252:113843
pubmed: 35577107
Neuron. 2014 Nov 5;84(3):564-71
pubmed: 25442935
J Affect Disord. 2021 May 15;287:54-68
pubmed: 33773359
Eat Behav. 2003 Jan;3(4):341-7
pubmed: 15000995
Am J Physiol. 1988 Sep;255(3 Pt 1):E332-7
pubmed: 3421330
Neurosci Biobehav Rev. 2022 Jan;132:142-153
pubmed: 34800584
Ann N Y Acad Sci. 2018 Jan;1411(1):96-105
pubmed: 29044551
J Endocrinol Invest. 2018 Jan;41(1):83-89
pubmed: 28741280
J Affect Disord. 2023 Jul 1;332:1-8
pubmed: 36963517
Neurosci Biobehav Rev. 2016 Jun;65:21-35
pubmed: 26959336
Diabetes. 2015 Aug;64(8):2859-67
pubmed: 25964395
Addict Behav. 1982;7(1):47-55
pubmed: 7080884
Eat Behav. 2016 Apr;21:214-9
pubmed: 27002703
Physiol Behav. 2006 Mar 30;87(3):487-92
pubmed: 16442572
J Clin Endocrinol Metab. 2013 Jul;98(7):2791-9
pubmed: 23666976

Auteurs

Andrés M Treviño-Alvarez (AM)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA. Electronic address: andres.trevino-alvarez@nih.gov.

Tomás Cabeza de Baca (T)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Emma J Stinson (EJ)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Marci E Gluck (ME)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Douglas C Chang (DC)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Paolo Piaggi (P)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Jonathan Krakoff (J)

Department of Health and Human Services, Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH